Genetic Technologies Ltd.
GENE
GENE was delisted on the 16th of October, 2024.
1 hedge funds and large institutions have $2.86K invested in Genetic Technologies Ltd. in 2024 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 9 closing their positions.
90% less funds holding
Funds holding: 10 → 1 (-9)
96% less capital invested
Capital invested by funds: $69.1K → $2.86K (-$66.3K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 9
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$20.7K |
| 2 |
Morgan Stanley
New York
|
-$15K |
| 3 |
BNP Paribas Financial Markets
Paris,
France
|
-$11.7K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$11.2K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$6.87K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
RhumbLine Advisers
Boston,
Massachusetts
| $2.86K | – | – | – |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$20.7K | -27,617 | Closed |
|
|
3
Morgan Stanley
New York
| – | -$15K | -19,389 | Closed |
|
|
4
BNP Paribas Financial Markets
Paris,
France
| – | -$11.7K | -15,100 | Closed |
|
|
TSS
5
Two Sigma Securities
New York
| – | -$11.2K | -14,457 | Closed |
|
|
6
UBS Group
Zurich,
Switzerland
| – | -$6.87K | -8,866 | Closed |
|
7
Citadel Advisors
Miami,
Florida
| – | -$510 | -682 | Closed |
|
|
FDCDDQ
8
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| – | -$310 | -400 | Closed |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| – | -$13 | -18 | Closed |
|
|
ATS
10
Ashton Thomas Securities
Rochester,
New York
| – | -$4 | -5 | Closed |
|
GENE Hedge Fund Activity: Q4 2024 in Review
1 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Genetic Technologies Ltd. (GENE) for Q4 2024, worth a combined $2.86K — down 96% from $69.1K a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of GENE and 0 opened new positions — a net loss of 9 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Susquehanna International Group, exiting entirely with an estimated $20.7K sold.
- 1 institutional investor held Genetic Technologies Ltd. (GENE) as of Q4 2024, down from 10 in Q3 2024.
- Funds reported $2.86K of Genetic Technologies Ltd. stock for Q4 2024, down 96% quarter-over-quarter.
- 0 funds opened new Genetic Technologies Ltd. positions in Q4 2024 and 9 closed out, a net change of -9 holders.
- The largest Genetic Technologies Ltd. seller in Q4 2024 was Susquehanna International Group, an estimated $20.7K sold.
Based on aggregated 13F filings for Q4 2024.